These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 34820745)

  • 41. Cortical thinning across Parkinson's disease stages and clinical correlates.
    Wilson H; Niccolini F; Pellicano C; Politis M
    J Neurol Sci; 2019 Mar; 398():31-38. PubMed ID: 30682518
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Brain Amyloid Contribution to Cognitive Dysfunction in Early-Stage Parkinson's Disease: The PPMI Dataset.
    Fiorenzato E; Biundo R; Cecchin D; Frigo AC; Kim J; Weis L; Strafella AP; Antonini A
    J Alzheimers Dis; 2018; 66(1):229-237. PubMed ID: 30282359
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [(11)C]PIB-, [(18)F]FDG-PET and MRI imaging in patients with Parkinson's disease with and without dementia.
    Jokinen P; Scheinin N; Aalto S; Någren K; Savisto N; Parkkola R; Rokka J; Haaparanta M; Röyttä M; Rinne JO
    Parkinsonism Relat Disord; 2010 Dec; 16(10):666-70. PubMed ID: 20870446
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Regional changes in the type 1 cannabinoid receptor are associated with cognitive dysfunction in Parkinson's disease.
    Ceccarini J; Casteels C; Ahmad R; Crabbé M; Van de Vliet L; Vanhaute H; Vandenbulcke M; Vandenberghe W; Van Laere K
    Eur J Nucl Med Mol Imaging; 2019 Oct; 46(11):2348-2357. PubMed ID: 31342135
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Neural correlates of distinct cognitive phenotypes in early Parkinson's disease.
    Bayram E; Bluett B; Zhuang X; Cordes D; LaBelle DR; Banks SJ
    J Neurol Sci; 2019 Apr; 399():22-29. PubMed ID: 30743154
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The Metabolic Pattern of Idiopathic REM Sleep Behavior Disorder Reflects Early-Stage Parkinson Disease.
    Meles SK; Renken RJ; Janzen A; Vadasz D; Pagani M; Arnaldi D; Morbelli S; Nobili F; Mayer G; Leenders KL; Oertel WH;
    J Nucl Med; 2018 Sep; 59(9):1437-1444. PubMed ID: 29476004
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Neural correlates of self-awareness of cognitive deficits in non-demented patients with Parkinson's disease.
    Yoo HS; Kwon H; Chung SJ; Sohn YH; Lee JM; Lee PH
    Eur J Neurol; 2021 Dec; 28(12):4022-4030. PubMed ID: 34478599
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cognitive performances and DAT imaging in early Parkinson's disease with mild cognitive impairment: a preliminary study.
    Pellecchia MT; Picillo M; Santangelo G; Longo K; Moccia M; Erro R; Amboni M; Vitale C; Vicidomini C; Salvatore M; Barone P; Pappatà S
    Acta Neurol Scand; 2015 May; 131(5):275-81. PubMed ID: 25644029
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Overlapping and distinct neural metabolic patterns related to impulsivity and hypomania in Parkinson's disease.
    Schwartz F; Tahmasian M; Maier F; Rochhausen L; Schnorrenberg KL; Samea F; Seemiller J; Zarei M; Sorg C; Drzezga A; Timmermann L; Meyer TD; van Eimeren T; Eggers C
    Brain Imaging Behav; 2019 Feb; 13(1):241-254. PubMed ID: 29322397
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Capturing subjective cognitive decline with a new combined index in low education patients with Parkinson's disease.
    Huang J; Wang H; Chen L; Hu B; Qin X; Yang Q; Cui Y; Chen S; Huang W
    Front Neurol; 2024; 15():1403105. PubMed ID: 39224881
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hypometabolism in Posterior and Temporal Areas of the Brain is Associated with Cognitive Decline in Parkinson's Disease.
    Tard C; Demailly F; Delval A; Semah F; Defebvre L; Dujardin K; Moreau C
    J Parkinsons Dis; 2015; 5(3):569-74. PubMed ID: 26406137
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Neural Correlates of Cognitive Impairment in Parkinson's Disease: A Review of Structural MRI Findings.
    Hall JM; Lewis SJG
    Int Rev Neurobiol; 2019; 144():1-28. PubMed ID: 30638452
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Unravelling neural correlates of empathy deficits in Subjective Cognitive Decline, Mild Cognitive Impairment and Alzheimer's Disease.
    Giacomucci G; Galdo G; Polito C; Berti V; Padiglioni S; Mazzeo S; Chiaro E; De Cristofaro MT; Bagnoli S; Nacmias B; Sorbi S; Bessi V
    Behav Brain Res; 2022 Jun; 428():113893. PubMed ID: 35429513
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Region-Specific Association of Subjective Cognitive Decline With Tauopathy Independent of Global β-Amyloid Burden.
    Buckley RF; Hanseeuw B; Schultz AP; Vannini P; Aghjayan SL; Properzi MJ; Jackson JD; Mormino EC; Rentz DM; Sperling RA; Johnson KA; Amariglio RE
    JAMA Neurol; 2017 Dec; 74(12):1455-1463. PubMed ID: 28973551
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Behavioural and neuroimaging correlates of impaired self-awareness of hypo- and hyperkinesia in Parkinson's disease.
    Maier F; Williamson KL; Tahmasian M; Rochhausen L; Ellereit AL; Prigatano GP; Kracht L; Tang CC; Herz DM; Fink GR; Timmermann L; Eggers C
    Cortex; 2016 Sep; 82():35-47. PubMed ID: 27341471
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Voxel-based meta-analysis of gray matter volume reductions associated with cognitive impairment in Parkinson's disease.
    Xu Y; Yang J; Hu X; Shang H
    J Neurol; 2016 Jun; 263(6):1178-87. PubMed ID: 27113603
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cerebral glucose metabolism of Parkinson's disease patients with mild cognitive impairment.
    Lyoo CH; Jeong Y; Ryu YH; Rinne JO; Lee MS
    Eur Neurol; 2010; 64(2):65-73. PubMed ID: 20606450
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Voxel-based quantitative susceptibility mapping in Parkinson's disease with mild cognitive impairment.
    Uchida Y; Kan H; Sakurai K; Arai N; Kato D; Kawashima S; Ueki Y; Matsukawa N
    Mov Disord; 2019 Aug; 34(8):1164-1173. PubMed ID: 31091347
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Tracking Cortical Changes Throughout Cognitive Decline in Parkinson's Disease.
    Filippi M; Canu E; Donzuso G; Stojkovic T; Basaia S; Stankovic I; Tomic A; Markovic V; Petrovic I; Stefanova E; Kostic VS; Agosta F
    Mov Disord; 2020 Nov; 35(11):1987-1998. PubMed ID: 32886420
    [TBL] [Abstract][Full Text] [Related]  

  • 60. In Vivo cortical tau in Parkinson's disease using 18F-AV-1451 positron emission tomography.
    Hansen AK; Damholdt MF; Fedorova TD; Knudsen K; Parbo P; Ismail R; Østergaard K; Brooks DJ; Borghammer P
    Mov Disord; 2017 Jun; 32(6):922-927. PubMed ID: 28256006
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.